Published in Neurology on October 11, 2005
Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis. Neurol Sci (2010) 1.18
Venous obstruction and jugular valve insufficiency in idiopathic intracranial hypertension. J Neurol (2009) 0.99
The relationship of transverse sinus stenosis to bony groove dimensions provides an insight into the aetiology of idiopathic intracranial hypertension. Neuroradiology (2008) 0.92
High-pressure headaches: idiopathic intracranial hypertension and its mimics. Nat Rev Neurol (2012) 0.91
Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol (2008) 0.89
The entire dural sinus tree is compressed in patients with idiopathic intracranial hypertension: a longitudinal, volumetric magnetic resonance imaging study. Neuroradiology (2011) 0.89
Monro-Kellie 2.0: The dynamic vascular and venous pathophysiological components of intracranial pressure. J Cereb Blood Flow Metab (2016) 0.88
Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression? Neurol Sci (2010) 0.88
Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol (2013) 0.84
Pseudotumor cerebri. Childs Nerv Syst (2010) 0.83
Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry (2007) 0.82
Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects. J Pain Res (2016) 0.80
Idiopathic intracranial hypertension and transverse sinus stenoses. BMJ Case Rep (2013) 0.75
Pseudotumor cerebri: an update on treatment options. Indian J Ophthalmol (2014) 0.75
Resolution of Pulsatile Tinnitus after Venous Sinus Stenting in Patients with Idiopathic Intracranial Hypertension. PLoS One (2016) 0.75
Quantitative imaging biomarkers for dural sinus patterns in idiopathic intracranial hypertension. Brain Behav (2017) 0.75
Transverse venous sinus stenosis and intracranial hypertension: evidence for which comes first. J Neurol (2007) 0.75
[Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension]. Ophthalmologe (2015) 0.75
Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults. J Neurol (2017) 0.75
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet (2000) 2.96
Neurophysiological correlates of age-related changes in human motor function. Neurology (2002) 2.52
Abnormal pressure waves in headache sufferers with bilateral transverse sinus stenosis. Cephalalgia (2010) 2.35
Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study. Neurology (2010) 2.27
Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem Biophys Res Commun (1993) 1.91
The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet (2000) 1.73
Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology (2006) 1.59
Polyradiculoneuropathy with cerebrospinal fluid albuminocytological dissociation due to neurobrucellosis. Clin Infect Dis (1996) 1.54
The parkin gene is not involved in late-onset Parkinson's disease. Neurology (2001) 1.51
MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study. Neurology (2011) 1.49
Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. Neurol Sci (2006) 1.48
The long-duration response to L-dopa in the treatment of early PD. Neurology (2000) 1.46
A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1. Neurology (2000) 1.45
A novel Angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy. Neuromuscul Disord (2007) 1.45
Gross morphology and morphometric sequelae in the hippocampus, fornix, and corpus callosum of patients with severe non-missile traumatic brain injury without macroscopically detectable lesions: a T1 weighted MRI study. J Neurol Neurosurg Psychiatry (2004) 1.44
Cerebral venous thrombosis and isolated intracranial hypertension without papilledema in CDH. Neurology (2001) 1.42
Cerebellar atrophy in essential tremor using an automated segmentation method. AJNR Am J Neuroradiol (2009) 1.30
Defining a neuron: neuronal ELAV proteins. Cell Mol Life Sci (2008) 1.22
The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry (2005) 1.19
Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet (1996) 1.13
A conserved AU-rich element in the 3' untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis. FASEB J (2000) 1.12
Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler (2006) 1.10
Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology (2005) 1.10
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat. Proc Natl Acad Sci U S A (1997) 1.09
Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. Neurology (2010) 1.08
GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology (2003) 1.06
Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD. Neurology (1999) 1.05
Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study. Neurology (2008) 1.04
Spatial learning induced changes in expression of the ryanodine type II receptor in the rat hippocampus. FASEB J (2000) 1.03
MRI evidence of mesial temporal sclerosis in sporadic "benign" temporal lobe epilepsy. Neurology (2006) 1.02
Natural history of CMT1A including QoL: a 2-year prospective study. Neuromuscul Disord (2008) 0.99
Loss of long-duration response to levodopa over time in PD: implications for wearing-off. Neurology (1999) 0.99
A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines. Oncogene (1996) 0.99
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology (2006) 0.97
A novel mutation (Thr116Ile) in the presenilin 1 gene in a patient with early-onset Alzheimer's disease. Eur J Neurol (2004) 0.96
AURA: Atlas of UTR Regulatory Activity. Bioinformatics (2011) 0.96
An antisense oligonucleotide on the mouse Shaker-like potassium channel Kv1.1 gene prevents antinociception induced by morphine and baclofen. J Pharmacol Exp Ther (1997) 0.96
The fragile X premutation presenting as postprandial hypotension. Neurology (2004) 0.95
Vitamin E deficiency due to chylomicron retention disease in Marinesco-Sjögren syndrome. Ann Neurol (2000) 0.95
Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. Br J Clin Pharmacol (1983) 0.95
Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study. Br J Cancer (2002) 0.94
Familial temporal lobe epilepsy autosomal dominant inheritance in a large pedigree from southern Italy. Epilepsy Res (2000) 0.91
Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study. Neurology (1998) 0.91
Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia (1999) 0.90
Subcortical motor plasticity in patients with sporadic ALS: An fMRI study. Brain Res Bull (2006) 0.90
Analysis of UbcH10 expression represents a useful tool for the diagnosis and therapy of astrocytic tumors. Clin Neuropathol (2008) 0.90
Effect of K+ channel modulation on mouse feeding behaviour. Eur J Pharmacol (1997) 0.90
CADASIL: extended polymorphisms and mutational analysis of the NOTCH3 gene. J Neurosci Res (2009) 0.90
Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol (2008) 0.89
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel. Eur J Pharmacol (1997) 0.89
A genome screen for multiple sclerosis in Italian families. Genes Immun (2001) 0.89
Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology (2002) 0.89
Spinal muscular atrophy due to an isolated deletion of exon 8 of the telomeric survival motor neuron gene. Ann Neurol (1998) 0.88
Synchronous pattern distinguishes resting tremor associated with essential tremor from rest tremor of Parkinson's disease. Parkinsonism Relat Disord (2010) 0.88
Extradural motor cortex stimulation (EMCS) for Parkinson's disease. History and first results by the study group of the Italian neurosurgical society. Acta Neurochir Suppl (2005) 0.88
Lamotrigine therapy for paroxysmal dysarthria caused by multiple sclerosis: a case report. J Neurol (2011) 0.88
DJ-1 is a Parkinson's disease susceptibility gene in southern Italy. Clin Genet (2009) 0.87
The upper limit of normal CSF opening pressure is related to bilateral transverse sinus stenosis in headache sufferers. Cephalalgia (2010) 0.87
Brainstem auditory evoked responses in Lafora disease. Clin Electroencephalogr (1985) 0.87
Neuroocular side effects of carbamazepine and phenobarbital in epileptic patients as measured by saccadic eye movements analysis. Epilepsia (1989) 0.87
Action palatal tremor in a patient with primary intestinal lymphoma. Mov Disord (1997) 0.86
Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease. Mov Disord (1997) 0.86
Osteoid osteomas of the spine. Surg Neurol (1986) 0.86
A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL. Neurology (2004) 0.86
Mild non-lesional temporal lobe epilepsy. A common, unrecognized disorder with onset in adulthood. Can J Neurol Sci (1998) 0.85
Suggestive evidence for linkage to chromosome 13qter for autosomal dominant type 1 porencephaly. Neurology (2004) 0.85
Relationship between high prolactin levels and migraine attacks in patients with microprolactinoma. J Headache Pain (2008) 0.85
Chordoid meningioma: case report and literature review. Ultrastruct Pathol (2006) 0.85
Met158 variant of the catechol-O-methyltransferase genotype is associated with thicker cortex in adult brain. Neuroscience (2010) 0.85
Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease. Ann Neurol (1997) 0.84
Subacute spongiform encephalopathy with periodic paroxysmal activities: clinical evolution and serial EEG findings in 20 cases. Clin Electroencephalogr (1987) 0.84
SIL1 and SARA2 mutations in Marinesco-Sjögren and chylomicron retention diseases. Clin Genet (2007) 0.84
Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study. Neurol Sci (2008) 0.84
Antinociceptive action of quipazine: relation to central serotonergic receptor stimulation. Psychopharmacologia (1976) 0.84
Pharmacodynamics of the long-duration response to levodopa in PD. Neurology (1999) 0.84
[Behavior of trigemino-facial reflexes in subjects with hemispheric lesions]. Riv Neurol (1974) 0.83
Usefulness of rectal biopsy for the diagnosis of Kufs disease: a controlled study and review of the literature. Eur J Neurol (2012) 0.83
Association of tau gene polymorphism with Parkinson's disease. Neurol Sci (2003) 0.83